Back to mobile site

HSBC Starts Actinium Pharma (ATNM) at Buy

September 6, 2023 3:13 AM EDT Send to a Friend
HSBC analyst Morten Herholdt initiates coverage on Actinium Pharma (NYSE: ATNM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login